Vertiv Holdings Co vs GeneDx Holdings Corp — how do they compare? Vertiv Holdings Co trades at $296 (market cap $108.49B), while GeneDx Holdings Corp trades at $82.37 (market cap $2.44B). The key difference: Vertiv Holdings Co is far larger — about 44.5× GeneDx Holdings Corp's market cap, and Vertiv Holdings Co pays a 0.09% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| VRT | WGS | |
|---|---|---|
Market Cap | $108.49B | $2.44B |
Sector | Technology | Technology |
52-Week High | $376.23 | $167.51 |
52-Week Low | $121.82 | $34.51 |
Enterprise Value | $108.72B | $2.48B |
Dividend Yield | 0.09% | — |
Signals from Pluang's Aura AI — not financial advice
Vertiv (VRT) trades at $297.49, up 10.14% in the last 24 hours, reflecting strong momentum driven by AI infrastructure demand. The stock exhibits a bullish technical trend with key resistance near $293 and support at $270. Fundamentally, the company shows robust growth with revenue rising to $10.23B in 2025 and net income reaching $1.33B, supported by a high ROE of 43.94%. Recent earnings beats and a consensus analyst price target of $386.58 highlight positive sentiment, though elevated valuation ratios like a P/E of 63.76 warrant caution.
The outlook for VRT remains positive due to its strategic position in the AI data center market, with projected revenue growth to $11.5B in 2026. However, risks include high valuation multiples, ongoing legal investigations, and dependence on tech sector capital expenditure cycles. Investors should weigh the growth potential against these factors, with analyst consensus strongly favoring a buy rating.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →